Literature DB >> 21333716

A non-canonical start codon in the Drosophila fragile X gene yields two functional isoforms.

R W Beerman1, T A Jongens.   

Abstract

Fragile X syndrome is caused by the loss of expression of the fragile X mental retardation protein (FMRP). As a RNA binding protein, FMRP functions in translational regulation, localization, and stability of its neuronal target transcripts. The Drosophila homologue, dFMR1, is well conserved in sequence and function with respect to human FMRP. Although dFMR1 is known to express two main isoforms, the mechanism behind production of the second, more slowly migrating isoform has remained elusive. Furthermore, it remains unknown whether the two isoforms may also contribute differentially to dFMR1 function. We have found that this second dFMR1 isoform is generated through an alternative translational start site in the dfmr1 5'UTR. This 5'UTR coding sequence is well conserved in the melanogaster group. Translation of the predominant, smaller form of dFMR1 (dFMR1-S(N)) begins at a canonical start codon (ATG), whereas translation of the minor, larger form (dFMR1-L(N)) begins upstream at a non-canonical start codon (CTG). To assess the contribution of the N-terminal extension toward dFMR1 activity, we generated transgenic flies that exclusively express either dFMR1-S(N) or dFMR1-L(N). Expression analyses throughout development revealed that dFMR1-S(N) is required for normal dFMR1-L(N) expression levels in adult brains. In situ expression analyses showed that either dFMR1-S(N) or dFMR1-L(N) is individually sufficient for proper dFMR1 localization in the nervous system. Functional studies demonstrated that both dFMR1-S(N) and dFMR1-L(N) can function independently to rescue dfmr1 null defects in synaptogenesis and axon guidance. Thus, dfmr1 encodes two functional isoforms with respect to expression and activity throughout neuronal development.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333716      PMCID: PMC3074047          DOI: 10.1016/j.neuroscience.2011.02.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  72 in total

Review 1.  P bodies: at the crossroads of post-transcriptional pathways.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Elisa Izaurralde
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

2.  P-body formation is a consequence, not the cause, of RNA-mediated gene silencing.

Authors:  Ana Eulalio; Isabelle Behm-Ansmant; Daniel Schweizer; Elisa Izaurralde
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

Review 3.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

4.  The fragile X mental retardation protein is associated with ribosomes.

Authors:  E W Khandjian; F Corbin; S Woerly; F Rousseau
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

5.  Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein.

Authors:  L Wan; T C Dockendorff; T A Jongens; G Dreyfuss
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.

Authors:  Bastian Linder; Oliver Plöttner; Matthias Kroiss; Enno Hartmann; Bernhard Laggerbauer; Gunter Meister; Eva Keidel; Utz Fischer
Journal:  Hum Mol Genet       Date:  2008-07-28       Impact factor: 6.150

7.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

8.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

9.  Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences.

Authors:  Stéphanie Bornes; Mathieu Boulard; Corinne Hieblot; Catherine Zanibellato; Jason S Iacovoni; Hervé Prats; Christian Touriol
Journal:  J Biol Chem       Date:  2004-02-05       Impact factor: 5.157

10.  Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes.

Authors:  Michele Markstein; Chrysoula Pitsouli; Christians Villalta; Susan E Celniker; Norbert Perrimon
Journal:  Nat Genet       Date:  2008-03-02       Impact factor: 38.330

View more
  11 in total

1.  A proteogenomic survey of the Medicago truncatula genome.

Authors:  Jeremy D Volkening; Derek J Bailey; Christopher M Rose; Paul A Grimsrud; Maegen Howes-Podoll; Muthusubramanian Venkateshwaran; Michael S Westphall; Jean-Michel Ané; Joshua J Coon; Michael R Sussman
Journal:  Mol Cell Proteomics       Date:  2012-07-05       Impact factor: 5.911

Review 2.  Proteomics of the Synapse--A Quantitative Approach to Neuronal Plasticity.

Authors:  Daniela C Dieterich; Michael R Kreutz
Journal:  Mol Cell Proteomics       Date:  2015-08-25       Impact factor: 5.911

Review 3.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

4.  Novel West syndrome candidate genes in a Chinese cohort.

Authors:  Jing Peng; Ying Wang; Fang He; Chen Chen; Li-Wen Wu; Li-Fen Yang; Yu-Ping Ma; Wen Zhang; Zi-Qing Shi; Chao Chen; Kun Xia; Hui Guo; Fei Yin; Nan Pang
Journal:  CNS Neurosci Ther       Date:  2018-04-17       Impact factor: 5.243

5.  CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome.

Authors:  Peter K Todd; Seok Yoon Oh; Amy Krans; Fang He; Chantal Sellier; Michelle Frazer; Abigail J Renoux; Kai-chun Chen; K Matthew Scaglione; Venkatesha Basrur; Kojo Elenitoba-Johnson; Jean P Vonsattel; Elan D Louis; Michael A Sutton; J Paul Taylor; Ryan E Mills; Nicholas Charlet-Berguerand; Henry L Paulson
Journal:  Neuron       Date:  2013-04-18       Impact factor: 17.173

Review 6.  Repeat-associated non-AUG translation and its impact in neurodegenerative disease.

Authors:  Michael G Kearse; Peter K Todd
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

7.  Gene Model Annotations for Drosophila melanogaster: The Rule-Benders.

Authors:  Madeline A Crosby; L Sian Gramates; Gilberto Dos Santos; Beverley B Matthews; Susan E St Pierre; Pinglei Zhou; Andrew J Schroeder; Kathleen Falls; David B Emmert; Susan M Russo; William M Gelbart
Journal:  G3 (Bethesda)       Date:  2015-06-24       Impact factor: 3.154

Review 8.  Non-AUG translation: a new start for protein synthesis in eukaryotes.

Authors:  Michael G Kearse; Jeremy E Wilusz
Journal:  Genes Dev       Date:  2017-09-01       Impact factor: 11.361

9.  The RNA-binding proteins FMR1, rasputin and caprin act together with the UBA protein lingerer to restrict tissue growth in Drosophila melanogaster.

Authors:  Roland Baumgartner; Hugo Stocker; Ernst Hafen
Journal:  PLoS Genet       Date:  2013-07-11       Impact factor: 5.917

Review 10.  Modeling Fragile X Syndrome in Drosophila.

Authors:  Małgorzata Drozd; Barbara Bardoni; Maria Capovilla
Journal:  Front Mol Neurosci       Date:  2018-04-16       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.